Patient safety


Access to treatments could reduce post-Brexit

UK patients are at risk of missing out on new treatments after Brexit if a deal is not struck, experts have warned.

Speaking at a Health Committee inquiry yesterday, Dr Jane Spink, chief executive of Genetic Alliance UK, cautioned that if the UK is unable to secure access to European research funding and collaboration as part of the Brexit negotiations, access to trials and medicines for rare diseases in the UK would likely reduce.

Having access to pan-Europeans trials, particularly in the context of a rare diseases, is really critically important because in many rare diseases there are no existing treatments, or existing treatments may be suboptimal,” she explained.

“For a large proportion of rare diseases, the conditions are degenerative, so your ability to access medicines early, even be that through a clinical trial, is incredibly important to patients with rare diseases.

“The least desirable scenario would be for trials to be ongoing in Europe to which UK patients have no access, and then to see products licensed in Europe to which UK patients have no access or delayed access.”

Aisling Burnand MBE, chief executive of the Association of Medical Research Charities, expressed concerns as to where the funding for research in the UK would come from post-2020.

In an ideal Brexit scenario, she said that patients would continue to have fast access to treatments and that there should be continued alignment and collaboration with EU member states.

Currently patients in countries such as Canada, Australia and Switzerland suffer delays of six to 12 months to access new treatments, which Burnand warned must be minimised in the UK.

She also explained that it is important that the UK continues to collaborate with experts across the EU, and for the UK’s young talent to be able to work with these experts and bring knowledge back to the country.

Dr. Beth Thompson, head of UK and EU policy at the Wellcome Trust, was optimistic that a positive agreement should be achievable because of the “mutual benefits.”

However, she warned that a ‘no deal’ Brexit would be extremely challenging because of funding, movement of people and regulatory alignment.

“If political will is there, we should be able to reach a good agreement,” Thompson concluded.

In August, the Brexit Health Alliance listed access to new medicines and healthcare research as some of the top issues in negotiations with Brussels, with NHS Confederation boss Niall Dickson arguing patients “stand to lose out” if these areas aren’t prioritised.

Have you got a story to tell? Would you like to become an NHE columnist? If so, click here.


Eric Nicholls   13/12/2017 at 22:52

Please encourage the re-establishment of close working relationships and collaborations with North America and those Commonwealth countries that strongly supported the Health Service for decades until 20 years ago when they were discouraged and people from the Continent were favoured. Don't despair and don't forget those from other nations that have done far more for the UK and for far longer than any and all of the EU countries.

Add your comment


national health executive tv

more videos >

latest healthcare news

Traffic light system could reduce hospital waiting times

24/04/2018Traffic light system could reduce hospital waiting times

A pilot system is making it easier for GPs to understand the hospital waiting times experienced by their patients. The e-traffic light system co... more >
Ambulance workers threatened with weapons and sexual violence

23/04/2018Ambulance workers threatened with weapons and sexual violence

Sexual assaults on ambulance workers have almost trebled in five years, a Freedom of Information (FoI) by union GMB has revealed. Since 2012 the... more >
RCN seeks views on three-year pay deal

23/04/2018RCN seeks views on three-year pay deal

The Royal College of Nursing (RCN) has opened its vote for its members to have their say on a three-year pay deal. If approved, the deal would s... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital e... read more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >

the scalpel's daily blog

NHS long-term funding: what’s in store?

10/04/2018NHS long-term funding: what’s in store?

Anita Charlesworth, director of research and economics at the Health Foundation, discusses Theresa May’s recent announcements on long-term NHS funding and considers the options available. The prime minister’s appearance in front of the Liaison Committee of the House of Commons last month has caused quite a stir in the health w... more >
read more blog posts from 'the scalpel' >


Building a solid evidence base

18/04/2018Building a solid evidence base

Danielle Doyle of THIS Institute, co-created by the University of Cambridge and the Health Foundation, says the new organisation will dare to try... more >
Forensics v fraud

18/04/2018Forensics v fraud

Gareth Ballance, technical lead of the Forensic Computing Unit (FCU), gives a snapshot of a day in the life working for the NHS Counter Fraud Aut... more >
A personal view of NAPP’s future strategy

18/04/2018A personal view of NAPP’s future strategy

Dr Patricia Wilkie, president of the National Association for Patient Participation (N.A.P.P.), outlines her personal ambitions for the coming ye... more >
It’s all about quality data

18/04/2018It’s all about quality data

Steve Graham, eProcurement/Scan4Safety lead at the Department of Health and Social Care (DHSC), and Gillian Fox, head of the eProcurement Program... more >


Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >
Tackling infection prevention locally

04/10/2017Tackling infection prevention locally

Dr Emma Burnett, a lecturer and researcher in infection prevention at the University of Dundee’s School of Nursing and Midwifery and a boar... more >
Scan4Safety: benefits across the whole supply chain

02/10/2017Scan4Safety: benefits across the whole supply chain

NHE interviews Gillian Fox, head of eProcurement (Scan4Safety) programme at NHS Supply Chain. How has the Scan4Safety initiative evolved sin... more >

health service focus

View all News